Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA

ClinicalTrials.gov ID: NCT03891875

Public ClinicalTrials.gov record NCT03891875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 9:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Masked, Placebo-Controlled Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Elamipretide in Subjects With Age-Related Macular Degeneration With Non-central Geographic Atrophy

Study identification

NCT ID
NCT03891875
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Stealth BioTherapeutics Inc.
Industry
Enrollment
176 participants

Conditions and interventions

Interventions

  • Subcutaneous elamipretide through the elamipretide delivery system Combination Product
  • Subcutaneos placebo through the elamipretide delivery system Combination Product

Combination Product

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2019
Primary completion
Feb 21, 2022
Completion
Apr 13, 2022
Last update posted
Jul 11, 2024

2019 – 2022

United States locations

U.S. sites
37
U.S. states
17
U.S. cities
33
Facility City State ZIP Site status
Associated Retina Consultants, Ltd. Peoria Arizona 85381
Retinal Research Institute, LLC Phoenix Arizona 85014
Arizona Retina & Vitreous Consultants Phoenix Arizona 85021
Retinal Research Institute, LLC Phoenix Arizona 85053
Global Retina Institute Scottsdale Arizona 85254
California Retina Consultants Bakersfield California 93309
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
Retina Institute of California Medical Group Palm Desert California 92260
California Retina Consultants Santa Barbara California 93103
California Retina Consultants Santa Maria California 93454
Bascom Palmer Eye Institute Miami Florida 33136
MedEye Associates Miami Florida 33143
Bascom Palmer Eye Institute Palm Beach Gardens Florida 33418
Center for Retina and Macular Disease Winter Haven Florida 33880
Southeast Retina Center, PC Augusta Georgia 30909
The Retina Care Center Baltimore Maryland 21209
Cumberland valley retina consultants Hagerstown Maryland 21740
Ophthalmic Consultants of Boston Boston Massachusetts 02114
New England Retina Consultants Springfield Massachusetts 01107
Specialty Eye Institute Jackson Michigan 49202
Retina Center of New Jersey LLC Bloomfield New Jersey 07003
New Jersey Retina Teaneck New Jersey 07666
Retina Associates of Western New York Rochester New York 14620
Duke Eye center Durham North Carolina 27705
Sterling Research Group Cincinnati Ohio 45202
Oklahoma University Health Sciences Center Oklahoma City Oklahoma 73104
Retina Northwest, P.C Portland Oregon 97221
Black Hills Regional Eye Institute Rapid City South Dakota 57701
Tennessee Retina Nashville Tennessee 37203
Retina Research Institute of Texas Abilene Texas 79606
Retina Research Center, PLLC Austin Texas 78705
Ophthalmology Associates Fort Worth Texas 76102
Texas Retina Associates Fort Worth Texas 76104
Retina Consultants of Houston, PA Houston Texas 77030
Retina Consultants of Houston Katy Texas 77494
Valley Retina Institute, PA McAllen Texas 78503
University of Virginia, Department of Ophthalmology Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03891875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2024 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03891875 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →